Rapid Succession of Multidrug-Resistant Bacteremia and Candidemia in a Patient with Refractory Pemphigus Vulgaris: A Lethal Therapeutic Challenge
Infection and Drug Resistance · 2026-09 · Volume 19 · 1-8
DOI: 10.2147/idr.s634408 ↗Kurz gefasst
Fallbericht in der Zeitschrift Infection and Drug Resistance, 2026-09. Verfasst von Ling Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management/International Medical Service, Chengdu Second People's Hospital, Chengdu, Sichuan, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Management/International Medical Service, Chengdu Second People's Hospital, Chengdu, Sichuan, People's Republic of China.
- Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu, Sichuan, People's Republic of China.
- West China School of Medicine, Sichuan University, Chengdu, Sichuan, People's Republic of China.
- Department of Dermatology, Chengdu Second People's Hospital, Chengdu, Sichuan, People's Republic of China.
ORCID-Profile: Ling Li
Zitieren
APA
Li, L., & Jiang, C. (2026). Rapid Succession of Multidrug-Resistant Bacteremia and Candidemia in a Patient with Refractory Pemphigus Vulgaris: A Lethal Therapeutic Challenge. Infection and Drug Resistance, Volume 19, 1-8. https://doi.org/10.2147/idr.s634408
Vancouver
Li L, Jiang C. Rapid Succession of Multidrug-Resistant Bacteremia and Candidemia in a Patient with Refractory Pemphigus Vulgaris: A Lethal Therapeutic Challenge. Infection and Drug Resistance. 2026;Volume 19:1-8. doi:10.2147/idr.s634408
BibTeX
@article{Li2026,
author = {Li, Ling and Jiang, Cunhuo},
title = {Rapid Succession of Multidrug-Resistant Bacteremia and Candidemia in a Patient with Refractory Pemphigus Vulgaris: A Lethal Therapeutic Challenge},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--8},
doi = {10.2147/idr.s634408}
}
EUVIMED